key: cord-1030428-ohxjwh50
authors: Khawaja, Uzzam Ahmed; Shamsoddin, Erfan; Desideri, Lorenzo Ferro; Tovani-Palone, Marcos Roberto
title: Infection of red blood cells by SARS-CoV-2: new evidence
date: 2021-04-08
journal: Einstein (Säo Paulo)
DOI: 10.31744/einstein_journal/2021ce6285
sha: f5ea1de5f0faba78c46016f5146cf6d0b41a7bdb
doc_id: 1030428
cord_uid: ohxjwh50

nan

einstein (São Paulo). 2021;19:1-2 Khawaja UA, Shamsoddin E, Desideri LF, Tovani-Palone MR interaction between the RBC Band 3 surface protein and the S1 spike protein in the SARS-CoV-2 virus, representing a possible entrance of SARS-CoV-2 into RBC. This hypothesis is of paramount significance as the integrity of the RBC Band 3 protein is mandatory for the RBC physiology. Alterations to this mechanism can lead to significant damages to the RBC functions, such as oxygen delivery. (5) In this case, hypoxia should ensue (as detected in severe COVID-19 cases) due to this interaction, which may decrease the oxygen transport through RBC.

Complementary to this, increased levels of glycolytic intermediates, accompanied by the oxidation and fragmentation of ankyrin, spectrin beta, and the N-terminal cytosolic domain of Band 3 (AE1) have been observed in COVID-19 patients. Significantly altered lipid metabolism was also noted, in particular, involving short-and medium-chain saturated fatty acids, acyl-carnitines, and sphingolipids. (3) These findings are of great importance given that recent evidence has delineated the significant positive association of RBC distribution width with mortality risk in hospitalized COVID-19 patients. (6) On the other hand, a previous study referred that RBC Band 3 protein acts as an entry point for merozoites from plasmodium falciparum into the RBC. However, based on the RRM model, it was found that the characteristic frequency for this parasite in merozoite form and the RBC Band 3 protein is different from the RRM frequency for SARS-CoV-2 and the RBC Band 3 protein, thereby suggesting the existence of different mechanisms for these two interactions. (4) This understanding is undoubtedly a key point for future studies that may establish more effective therapeutic protocols for the treatment of COVID-19 severe cases.

In summary, in light of the hypothesis stated above, we expect that effective improvements will be provided for the management of severe cases of the disease, and especially with regard to devising therapeutic regimens that help to maintain the RBC functions. (4) In this context, it should be clear to all health professionals that COVID-19 is a systemic disease and therefore may affect other organs besides the lungs. (1, 2) In this way, it is imperative that advances regarding the pathophysiology of the disease would be taken into account in clinical settings (either private or public facilities) and hospital practice.

Khawaja UA: http://orcid.org/0000-0002-8442-5174 Shamsoddin E: http://orcid.org/0000-0003-4789-3697 Desideri LF: http://orcid.org/0000-0003-0715-6369 Tovani-Palone MR: http://orcid.org/0000-0003-1149-2437

Epidemiology and clinical features of COVID-19: a review of current literature

Epidemiologic and clinical features of patients with COVID-19 in Brazil. einstein (São Paulo)

Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients

RRM prediction of erythrocyte band 3 protein as alternative receptor for SARS-CoV-2 virus

Hemolytic anemias: red blood cell membrane and metabolic defects

Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection